Mylan to Pay $465 Million in EpiPen Settlement

Mylan agreed to pay $465 million to settle allegations it overcharged the government for its EpiPen products, the latest move by the embattled pharmaceuticals firm to quell the furor over its pricing practices.

Source: WSJ.com: Health - October 7, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news